Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS
· Delayed Price · Currency is USD
0.114
-0.007 (-5.79%)
Dec 4, 2024, 4:00 PM EST
PVCT Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 0.19 | 0.08 | 0.02 | 0.68 | 0.1 | 0.59 | Upgrade
|
| Cash & Short-Term Investments | 0.19 | 0.08 | 0.02 | 0.68 | 0.1 | 0.59 | Upgrade
|
| Cash Growth | -48.96% | 254.44% | -96.84% | 602.43% | -83.54% | 1058.57% | Upgrade
|
| Accounts Receivable | - | 0 | 0 | - | - | - | Upgrade
|
| Other Receivables | - | - | - | 0.01 | 0 | - | Upgrade
|
| Receivables | - | 0 | 0 | 0.01 | 0 | - | Upgrade
|
| Prepaid Expenses | 0.15 | 0.34 | 0.47 | 0.33 | 0.32 | 0.35 | Upgrade
|
| Restricted Cash | 0.43 | 0.95 | 1.41 | 2.42 | - | - | Upgrade
|
| Other Current Assets | - | - | - | - | - | 0.06 | Upgrade
|
| Total Current Assets | 0.76 | 1.36 | 1.9 | 3.44 | 0.42 | 1 | Upgrade
|
| Property, Plant & Equipment | 0.04 | 0.08 | 0.14 | 0.07 | 0.17 | 0.25 | Upgrade
|
| Other Intangible Assets | - | - | - | - | - | 0.23 | Upgrade
|
| Total Assets | 0.8 | 1.45 | 2.04 | 3.51 | 0.59 | 1.48 | Upgrade
|
| Accounts Payable | 1.38 | 1.68 | 2.09 | 1.29 | 0.96 | 1.13 | Upgrade
|
| Accrued Expenses | 1.69 | 3.39 | 2.48 | 2.02 | 6.04 | 1.09 | Upgrade
|
| Short-Term Debt | 0.11 | 0.28 | 0.24 | 0.24 | 0.21 | 0.23 | Upgrade
|
| Current Portion of Long-Term Debt | 2.65 | 2.68 | 1.83 | 1.46 | 23.42 | 0.5 | Upgrade
|
| Current Portion of Leases | 0.04 | 0.05 | 0.04 | 0.05 | 0.08 | 0.08 | Upgrade
|
| Current Unearned Revenue | 0.35 | 0.95 | 1.51 | 2.5 | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | 0.15 | - | - | Upgrade
|
| Total Current Liabilities | 6.22 | 9.02 | 8.19 | 7.7 | 30.71 | 3.02 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.04 | 19.67 | Upgrade
|
| Long-Term Leases | - | 0.03 | 0.07 | - | 0.04 | 0.13 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 2.73 | Upgrade
|
| Total Liabilities | 6.22 | 9.04 | 8.27 | 7.7 | 30.8 | 25.55 | Upgrade
|
| Common Stock | 0.42 | 0.42 | 0.42 | 0.42 | 0.4 | 0.39 | Upgrade
|
| Additional Paid-In Capital | 249.26 | 244.71 | 242.95 | 241.44 | 209.92 | 209.38 | Upgrade
|
| Retained Earnings | -255.06 | -252.69 | -249.59 | -246.03 | -240.49 | -233.82 | Upgrade
|
| Comprehensive Income & Other | -0.06 | -0.06 | -0.04 | -0.03 | -0.03 | -0.02 | Upgrade
|
| Total Common Equity | -5.44 | -7.62 | -6.25 | -4.21 | -30.21 | -24.07 | Upgrade
|
| Shareholders' Equity | -5.42 | -7.59 | -6.23 | -4.19 | -30.21 | -24.07 | Upgrade
|
| Total Liabilities & Equity | 0.8 | 1.45 | 2.04 | 3.51 | 0.59 | 1.48 | Upgrade
|
| Total Debt | 2.8 | 3.03 | 2.18 | 1.74 | 23.8 | 20.6 | Upgrade
|
| Net Cash (Debt) | -2.61 | -2.95 | -2.16 | -1.06 | -23.7 | -20.01 | Upgrade
|
| Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.00 | -0.06 | -0.05 | Upgrade
|
| Filing Date Shares Outstanding | 420.28 | 419.52 | 419.5 | 419.45 | 403.56 | 390.69 | Upgrade
|
| Total Common Shares Outstanding | 420.28 | 419.52 | 419.5 | 419.45 | 398.81 | 389.89 | Upgrade
|
| Working Capital | -5.46 | -7.65 | -6.29 | -4.26 | -30.29 | -2.03 | Upgrade
|
| Book Value Per Share | -0.01 | -0.02 | -0.01 | -0.01 | -0.08 | -0.06 | Upgrade
|
| Tangible Book Value | -5.44 | -7.62 | -6.25 | -4.21 | -30.21 | -24.3 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.02 | -0.01 | -0.01 | -0.08 | -0.06 | Upgrade
|
| Machinery | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.